IMMP Immutep Limited ADRs

Immutep Ltd, formerly Prima Biomed Ltd is a biotechnology company. It is engaged in the development of immunotherapeutic products for cancer and autoimmune disease. Their operations are based in Australia and Europe. This is an ADR of a company whose stock trades outside of the U.S. as the symbol AT:IMM.

$2.02  +0.01 (0.50%)
As of 06/30/2022 15:29:04 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Australia
Country of incorporation:  Australia
IPO date:  02/11/2013
Outstanding shares:  86,623,982
Average volume:  178,886
Market cap:   $173,247,964
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   1.58
PS ratio:   13.27
Return on equity:   -18.11%
Net income %:   -151.07%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy